Correction to Early versus delayed initiation of highly active antiretroviral therapy for HIV-positive adults with newly diagnosed pulmonary tuberculosis (TB-HAART): A prospective, international, randomised, placebo-controlled trial [Lancet Infect Dis, 14, (2014) 563-71]

摘要

Mfinanga SG, Kirenga B), Chanda DM, et al. Early versus delayed initiation of highly active antiretrovira/ therapy for HIV-positive adults with newly diagnosed pulmonary tuberculosis (TB-HAART): a prospective, international, randomised, placebo-controlled trial. Lancet Infect Dis 2014; 14: 563-71-In this Article, the numbers at risk and events reported in figure 2 were incorrect. Furthermore, figure 2C shows patients with CD3 counts of 350 cells per ui or greater. These corrections have been made to the online version as of Aug 25,2014.